A Vicious Cycle of Osteosarcopeniain Inflammatory Bowel Diseases-Aetiology, Clinical Implications and Therapeutic Perspectives.
Dorota SkrzypczakAlicja Ewa Ratajczak-PawłowskaAleksandra Szymczak-TomczakAgnieszka DobrowolskaPiotr EderIwona Krela-KaźmierczakPublished in: Nutrients (2021)
Sarcopenia is a disorder characterized by a loss of muscle mass which leads to the reduction of muscle strength and a decrease in the quality and quantity of muscle. It was previously thought that sarcopenia was specific to ageing. However, sarcopenia may affect patients suffering from chronic diseases throughout their entire lives. A decreased mass of muscle and bone is common among patients with inflammatory bowel disease (IBD). Since sarcopenia and osteoporosis are closely linked, they should be diagnosed as mutual consequences of IBD. Additionally, multidirectional treatment of sarcopenia and osteoporosis including nutrition, physical activity, and pharmacotherapy should include both disorders, referred to as osteosarcopenia.
Keyphrases
- skeletal muscle
- physical activity
- bone mineral density
- community dwelling
- end stage renal disease
- postmenopausal women
- patients with inflammatory bowel disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- body mass index
- body composition
- quality improvement
- depressive symptoms
- patient reported outcomes
- soft tissue
- bone loss
- sleep quality